Full Length Research Paper
References
|
Angel A, Vaillant J, Ahmad Q(2020), Interleukins. Published in Stat Pearls Publishing LLC. ( http:/creative commons.org/license/by/4.0) |
|
|
Cuffari B (2021).. What is a Cytokine Storm? News Medical Life Sciences. 5th May. |
|
|
Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Girard JP (2007). IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proceedings of the National Academy of Sciences 104(1):282-287. |
|
|
Cayrol C, Girard JP (2018). Interleukin?33 (IL?33): a nuclear cytokine from the IL?1 family. Immunological reviews 281(1):154-168. |
|
|
Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, Gnjatic S (2020). An inflammatory cytokine signature predicts COVID-19 severity and survival. Nature medicine 26(10):1636-1643. |
|
|
Dinarello CA (2007). Historical insights into cytokines. European Journal of Immunology 37(1):34-45. |
|
|
Ferrara JM, Abhyankar S, Gilliland DG (1993). Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplantation Proceedings 25(1):1216-1217. |
|
|
Fields JK, Günther S, Sundberg EJ (2019). Structural basis of IL-1 family cytokine signaling. Frontiers in immunology 10:1412 :1-20 |
|
|
Gao YM, Xu G, Wang B, Liu BC (2021). Cytokine storm syndrome in coronavirus disease 2019: A narrative review. Journal of Internal Medicine 289(2):147-161. |
|
|
Ge Y, Huang M, Yao YM (2020). Biology of interleukin-17 and its pathophysiological significance in sepsis. Frontiers in Immunology 11 1558: 1-13. |
|
|
Gulati K, Guhathakurta S, Joshi J, Rai N, Ray AJMI (2016). Cytokines and their role in health and disease: a brief overview. MOJ Immunology 4(2):1-9. |
|
|
Hirano T (2014). Revisiting the 1986 molecular cloning of interleukin 6. Frontiers in Immunology 5(456):1-3. |
|
|
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kishimoto T (1986). Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324(6092):73-76. |
|
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cao B (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet 395(10223):497-506. |
|
|
Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei, H. Y. (2005). An interferon?γ?related cytokine storm in SARS patients. Journal of Medical Virology 75(2):185-194. |
|
|
Hunter CA, Jones SA (2015). IL-6 as a keystone cytokine in health and disease. Nature Immunology 16(5):448-457. |
|
|
Jin W, Dong C (2013). IL-17 cytokines in immunity and inflammation. Emerging microbes and infections 2(1):1-5. |
|
|
Liji T (2021). Novel Host-viral -microbiome interactions during COVIS-19 may determine outcome. News Medical Life Sciences. |
|
|
Luke YC, Biggs CM, Jamal S, Stukas S, Wellington CL, Sekhon MS (2021). Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome. Cell Reports Medicine 2(5):100269. March (2021). |
|
|
Mauer J, Denson JL, Brüning JC (2015). Versatile functions for IL-6 in metabolism and cancer. Trends in immunology 36(2):92-101. |
|
|
Monin L, Gaffen SL (2018). Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications. Cold Spring Harbor perspectives in biology 10(4):a028522. |
|
|
Onishi RM, Gaffen SL (2010).Interleukin?17 and its target genes: mechanisms of interleukin?17 function in disease. Immunology 129(3):311-321. |
|
|
Sinha P (2020). Is Cytokine storm a relevant to COVID-19? JAMA Internal Medicine 180(9):1152-1154.. |
|
|
Ronan Le Goffic, Arshad MI, Rauch M, L'Helgoualc'h, A, Delmas B, Piquet-Pellorce C,Samson M (2011).Infection with influenza virus induces IL-33 in murine lungs. American Journal of Respiratory cell and molecular biology 45(6):1125-1132. |
|
|
Rose-John S (2018). Interleukin-6 family cytokines. Cold Spring Harbor perspectives in biology 10(2):a028415. |
|
|
Satyesh CR (2020). Corona Virus-Origin, Replication and Remedy for Future Threat. Science and Culture 86(6):137-143. |
|
|
Satyesh CR (2021). Corona Virus and Pandemic. Published in Lambert Academic Publishing . An International Book Service Ltd. Member of Omni Scriptum Publishing Group. Mauritius. |
|
|
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Kastelein RA (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479-490. |
|
|
Taga T, Kishimoto T (1997). Gp130 and the interleukin-6 family of cytokines. Annual Review of Immunology 15(1):797-819. |
|
|
Tanaka T, Narazaki M, Ogata A, Kishimoto T (2014).A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. In Seminars in immunology 26(1):88-96. Academic Press. |
|
|
Turner MD, Nedjai B, Hurst T, Pennington DJ (2014). Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1843(11):2563-2582. |
|
|
Xiaoping Z, Angkasekwinai P, Dong C, Tang H (2011). Structure and function of interleukin-17 family cytokines. Protein and Cell 2(1):26-40. |
|
|
Xinvang S, He X, Li X, Qian Y (2016). The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity. Cellular and Molecular Immunology 13(4):418-431. |
|
|
Zizzo G, Cohen PL (2020). Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?. The Lancet Rheumatology. www.thelancet.com/rheumatology Vol 2 December 2020 |
|
|
Zhang JM, An J (2007). Cytokines, inflammation and pain. International anesthesiology clinics 45(2):27. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
